C. Simone

发表

Stem cell transplantation for amyotrophic lateral sclerosis: therapeutic potential and perspectives on clinical translation

N. Bresolin, G. Comi, S. Corti, 2014, Cellular and Molecular Life Sciences.

Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model

S. Salani, F. Rizzo, N. Bresolin, 2013, Human molecular genetics.

Pluripotent stem cell-based models of spinal muscular atrophy

S. Salani, S. Corti, F. Magri, 2015, Molecular and Cellular Neuroscience.

Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS

S. Corti, I. Allodi, E. Hedlund, 2016, Scientific Reports.

Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of amyotrophic lateral sclerosis.

S. Salani, C. Donadoni, N. Bresolin, 2010, Human molecular genetics.

Morpholino-mediated SOD1 reduction ameliorates an amyotrophic lateral sclerosis disease phenotype

F. Rizzo, N. Bresolin, G. Comi, 2016, Scientific Reports.

Is spinal muscular atrophy a disease of the motor neurons only: pathogenesis and therapeutic implications?

S. Corti, D. Re, H. Rideout, 2015, Cellular and Molecular Life Sciences.

iPSC-Derived Neural Stem Cells Act via Kinase Inhibition to Exert Neuroprotective Effects in Spinal Muscular Atrophy with Respiratory Distress Type 1

S. Salani, F. Rizzo, N. Bresolin, 2014, Stem cell reports.

Human motor neuron generation from embryonic stem cells and induced pluripotent stem cells

G. Comi, S. Corti, G. Riboldi, 2010, Cellular and Molecular Life Sciences.

Direct Reprogramming of Adult Somatic Cells into other Lineages: Past Evidence and Future Perspectives

N. Bresolin, G. Comi, S. Corti, 2013, Cell transplantation.

Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches

S. Salani, F. Rizzo, N. Bresolin, 2015, Scientific Reports.

Genetic Correction of Human Induced Pluripotent Stem Cells from Patients with Spinal Muscular Atrophy

S. Salani, C. Donadoni, F. Rizzo, 2012, Science Translational Medicine.

Direct reprogramming of human astrocytes into neural stem cells and neurons

S. Salani, C. Donadoni, F. Rizzo, 2012, Experimental cell research.

Patients with Spinal Muscular Atrophy Genetic Correction of Human Induced Pluripotent Stem Cells from

S. Salani, C. Donadoni, F. Rizzo, 2012 .

Antisense Oligonucleotide Therapy for the Treatment of C9ORF72 ALS/FTD Diseases

N. Bresolin, G. Comi, S. Corti, 2014, Molecular Neurobiology.

Beta-lactam antibiotic offers neuroprotection in a spinal muscular atrophy model by multiple mechanisms

S. Salani, C. Donadoni, N. Bresolin, 2011, Experimental Neurology.

ALS genetic modifiers that increase survival of SOD1 mice and are suitable for therapeutic development

N. Bresolin, G. Comi, S. Corti, 2011, Progress in Neurobiology.

Molecular therapeutic strategies for spinal muscular atrophies: current and future clinical trials.

N. Bresolin, G. Comi, S. Corti, 2014, Clinical therapeutics.

Embryonic stem cell-derived neural stem cells improve spinal muscular atrophy phenotype in mice.

S. Salani, C. Donadoni, N. Bresolin, 2010, Brain : a journal of neurology.

Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis

S. Salani, F. Rizzo, S. Corti, 2013, Cellular and Molecular Life Sciences.

Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis

S. Salani, F. Rizzo, S. Corti, 2013, Cellular and Molecular Life Sciences.

F. Rizzo, N. Bresolin, G. Comi, 2015, Journal of the Neurological Sciences.

Motor neuron derivation from human embryonic and induced pluripotent stem cells: experimental approaches and clinical perspectives

S. Corti, M. Nizzardo, M. Bucchia, 2014, Stem Cell Research & Therapy.

Therapeutic development in amyotrophic lateral sclerosis.

S. Corti, F. Magri, A. Ramirez, 2015, Clinical therapeutics.

Review Article Therapeutic Development in Amyotrophic Lateral Sclerosis

S. Corti, F. Magri, A. Ramirez, 2015 .

Effect of combined systemic and local morpholino treatment on the spinal muscular atrophy Δ7 mouse model phenotype.

S. Salani, F. Rizzo, N. Bresolin, 2014, Clinical therapeutics.

Research advances in gene therapy approaches for the treatment of amyotrophic lateral sclerosis

F. Rizzo, N. Bresolin, S. Corti, 2011, Cellular and Molecular Life Sciences.

Molecular, genetic and stem cell-mediated therapeutic strategies for spinal muscular atrophy (SMA)

N. Bresolin, G. Comi, S. Corti, 2014, Journal of cellular and molecular medicine.

Research advances in gene therapy approaches for the treatment of amyotrophic lateral sclerosis

F. Rizzo, N. Bresolin, G. Comi, 2012, Cellular and Molecular Life Sciences.

Is spinal muscular atrophy a disease of the motor neurons only: pathogenesis and therapeutic implications?

S. Corti, H. Rideout, A. Ramirez, 2016, Cellular and Molecular Life Sciences.

Stem cell transplantation for amyotrophic lateral sclerosis: therapeutic potential and perspectives on clinical translation

N. Bresolin, G. Comi, S. Corti, 2014, Cellular and Molecular Life Sciences.

Motor neurons with differential vulnerability to degeneration show distinct protein signatures in health and ALS

S. Corti, I. Allodi, E. Hedlund, 2015, Neuroscience.

Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model

S. Salani, F. Rizzo, N. Bresolin, 2015, Science Advances.

The wide spectrum of clinical phenotypes of spinal muscular atrophy with respiratory distress type 1: A systematic review

S. Corti, G. Riboldi, F. Magri, 2014, Journal of the Neurological Sciences.

Antisense Oligonucleotide Therapy for the Treatment of C9ORF72 ALS/FTD Diseases

N. Bresolin, G. Comi, S. Corti, 2014, Molecular Neurobiology.

Motor neurons with differential vulnerability to degeneration show distinct protein signatures in health and ALS

S. Corti, I. Allodi, E. Hedlund, 2015, Neuroscience.